SCHEMBL1965523

SCHEMBL1965523

CC(C)CCNC(=S)NN

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
LMNA P02545 4/20 0.47
ALOX12 P18054 2/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 4/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 1/20 0.44
MEN1 O00255 1/20 0.41
GLA P06280 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
GAA P10253 3/20 0.41
TAAR1 Q96RJ0 1/20 0.41
ANPEP P15144 4/20 0.40
RNPEP Q9H4A4 3/20 0.40
DNPEP Q9ULA0 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5069319 0.85 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL20085631 0.79 ALDH1A1 (0.53) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL20085632 0.77 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL12787075 0.77 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL12727665 0.77 GAA (0.52) ALDH1A1CYP3A4CYP2C9CYP2C19LMNA
SCHEMBL1101335 0.76
SCHEMBL1489044 0.76
Hydrochloric Acid SCHEMBL8718980 0.76 ANPEP (0.52) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL3614953 0.73
SCHEMBL1488883 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
EP-2334670-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES Almirall S.A. (ES) 2011-06-22 EP disclosed
WO-2010043377-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2010-04-22 WO disclosed
EP-2177521-A1 New 2-Amidothiadiazole Derivatives Almirall, S.A. (ES) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES S1PR2, S1PR3, S1PR1 ALDH1A1 1610/4885CYP1A2 1889/4885CYP3A4 3201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.